Position in REGN
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$1,063,135
-$273,532 QoQ
Shares Held
1,705
-1.4% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
#632
of 1,322 holders
Holding Since
Mar 2021
14 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Oak Grove Capital LLC holds $1,063,135 across 1 Biotechnology name. REGN ranks #1 (100.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
1,705 | $1,063,135 |
All Filings in REGN
Export CSV
14 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,063,135 | 1,705 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $1,336,667 | 1,730 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $1,335,335 | 1,730 | Shares | Sole | 2026-02-26 | |
| 2025-09-30 | $1,000,840 | 1,780 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $1,354,500 | 2,580 | Shares | Sole | 2025-08-01 | |
| 2025-03-31 | $1,921,716 | 3,030 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $2,087,126 | 2,930 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $2,081,455 | 1,980 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $1,996,957 | 1,900 | Shares | Sole | 2024-08-05 | |
| 2022-03-31 | $467,941 | 670 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $612,574 | 970 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $617,283 | 1,020 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $525,027 | 940 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $340,660 | 720 | Shares | Sole | 2021-05-11 | |
| No filing history on record for this holder in this stock. | ||||||